Home

AtriCure, Inc. - Common Stock (ATRC)

33.40
+0.00 (0.00%)
NASDAQ · Last Trade: Apr 28th, 9:36 AM EDT
QuoteNewsPress ReleasesChartHistoricalFAQAboutCompetitors
11 Analysts Have This To Say About AtriCurebenzinga.com
Via Benzinga · March 21, 2025
Earnings Scheduled For February 12, 2025benzinga.com
Via Benzinga · February 12, 2025
Expert Outlook: AtriCure Through The Eyes Of 5 Analystsbenzinga.com
Via Benzinga · February 10, 2025
Apple To $183? Here Are 10 Top Analyst Forecasts For Wednesdaybenzinga.com
Via Benzinga · January 22, 2025
Deep Dive Into AtriCure Stock: Analyst Perspectives (9 Ratings)benzinga.com
Via Benzinga · January 22, 2025
Cracking The Code: Understanding Analyst Reviews For AtriCurebenzinga.com
Via Benzinga · December 9, 2024
Snap Posts Upbeat Earnings, Joins Unisys, AtriCure, Garmin And Other Big Stocks Moving Higher On Wednesdaybenzinga.com
Via Benzinga · October 30, 2024
Navigating 6 Analyst Ratings For AtriCurebenzinga.com
Via Benzinga · July 31, 2024
Analyst Ratings For AtriCurebenzinga.com
Via Benzinga · July 8, 2024
12 Health Care Stocks Moving In Wednesday's Pre-Market Sessionbenzinga.com
Via Benzinga · October 30, 2024
12 Health Care Stocks Moving In Tuesday's After-Market Sessionbenzinga.com
Via Benzinga · October 29, 2024
ATRC Stock Earnings: AtriCure Meets EPS, Beats Revenue for Q2 2024investorplace.com
ATRC stock results show that AtriCure met analyst estimates for earnings per share but beat on revenue for the second quarter of 2024.
Via InvestorPlace · July 30, 2024
Have 20 Bucks? 7 Low-Priced Stocks That Could Double by 2025investorplace.com
Low priced stocks to buy for growth provide great value to investors in the $20 range and are expected to pop before 2025.
Via InvestorPlace · June 28, 2024
12 Health Care Stocks Moving In Tuesday's Intraday Sessionbenzinga.com
Via Benzinga · June 18, 2024
Cracking The Code: Understanding Analyst Reviews For AtriCurebenzinga.com
Via Benzinga · May 2, 2024
Key Takeaways From AtriCure Analyst Ratingsbenzinga.com
Via Benzinga · April 10, 2024
Cracking The Code: Understanding Analyst Reviews For AtriCurebenzinga.com
Via Benzinga · February 16, 2024
ATRC Stock Earnings: AtriCure Misses EPS, Beats Revenue for Q1 2024investorplace.com
ATRC stock results show that AtriCure missed analyst estimates for earnings per share but beat on revenue for the first quarter of 2024.
Via InvestorPlace · May 1, 2024
Coinbase To Rally Around 45%? Here Are 10 Top Analyst Forecasts For Fridaybenzinga.com
Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades and downgrades, please see our analyst ratings page.
Via Benzinga · February 16, 2024
Recap: AtriCure Q4 Earningsbenzinga.com
Via Benzinga · February 15, 2024
Earnings Scheduled For February 15, 2024benzinga.com
Companies Reporting Before The Bell • Cognex (NASDAQ:CGNX) is estimated to report quarterly earnings at $0.10 per share on revenue of $188.59 million.
Via Benzinga · February 15, 2024
AtriCure's Earnings: A Previewbenzinga.com
Via Benzinga · February 14, 2024
12 Health Care Stocks Moving In Thursday's Pre-Market Sessionbenzinga.com
Via Benzinga · January 18, 2024
Key Takeaways From AtriCure Analyst Ratingsbenzinga.com
Via Benzinga · January 4, 2024
Where AtriCure Stands With Analystsbenzinga.com
Via Benzinga · November 29, 2023